HK1218079A1 - 亞硝酸鹽的藥物製劑及其用途 - Google Patents
亞硝酸鹽的藥物製劑及其用途Info
- Publication number
- HK1218079A1 HK1218079A1 HK16106249.8A HK16106249A HK1218079A1 HK 1218079 A1 HK1218079 A1 HK 1218079A1 HK 16106249 A HK16106249 A HK 16106249A HK 1218079 A1 HK1218079 A1 HK 1218079A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nitrite
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361767017P | 2013-02-20 | 2013-02-20 | |
| PCT/US2014/017432 WO2014130691A2 (en) | 2013-02-20 | 2014-02-20 | Pharmaceutical formulations of nitrite and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1218079A1 true HK1218079A1 (zh) | 2017-02-03 |
Family
ID=51391970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16106249.8A HK1218079A1 (zh) | 2013-02-20 | 2016-06-02 | 亞硝酸鹽的藥物製劑及其用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9561249B2 (zh) |
| EP (1) | EP2958573B1 (zh) |
| JP (1) | JP2016509030A (zh) |
| KR (1) | KR102472588B1 (zh) |
| CN (1) | CN105358160A (zh) |
| AU (1) | AU2014218916A1 (zh) |
| BR (1) | BR112015019802A2 (zh) |
| CA (1) | CA2899602C (zh) |
| DK (1) | DK2958573T3 (zh) |
| ES (1) | ES2741146T3 (zh) |
| HK (1) | HK1218079A1 (zh) |
| WO (1) | WO2014130691A2 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2219657A4 (en) * | 2007-11-15 | 2020-01-08 | Louisiana State University | USE OF NITRITE SALTS IN CHRONIC ISCHEMIA |
| WO2014130691A2 (en) * | 2013-02-20 | 2014-08-28 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| GB201602959D0 (en) | 2016-02-19 | 2016-04-06 | Isis Innovation | Use of cerebral nitric oxide donors in the assessment of the extent of brain dyfunction following injury |
| US20170349438A1 (en) * | 2016-06-06 | 2017-12-07 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| WO2019013324A1 (ja) * | 2017-07-14 | 2019-01-17 | 国立大学法人大阪大学 | スパースモデリングを利用した痛みの分類および瞬間痛の判別 |
| CN108785106B (zh) * | 2018-06-05 | 2021-03-16 | 中国科学院上海硅酸盐研究所 | 一种胶状含银磷酸钙纳米复合材料及其制备方法和应用 |
| WO2020141546A1 (en) | 2019-01-02 | 2020-07-09 | Celagenex Research (India) Pvt. Ltd. | Synergistic nutritional compositions for pain management |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4650484A (en) | 1983-02-03 | 1987-03-17 | Alza Corporation | Method for treating ischemic conditions |
| IE64726B1 (en) | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
| US5122384A (en) | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5278192A (en) | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
| US20110196039A9 (en) | 1994-10-05 | 2011-08-11 | Kaesemeyer Wayne H | Controlled release arginine formulations |
| US5648101A (en) * | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
| US5692500A (en) * | 1995-01-09 | 1997-12-02 | Gaston-Johansson; Fannie | Pain measurement and recording tool and method |
| US5770645A (en) | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
| US5994444A (en) | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
| US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
| US7015876B1 (en) | 1998-06-03 | 2006-03-21 | Lear Corporation | Heads-up display with improved contrast |
| WO2000003725A1 (en) | 1998-07-14 | 2000-01-27 | Paracelsian, Inc. | Method for identifying and confirming consistent bio-functionality of natural compositions |
| AU764469B2 (en) | 1999-01-29 | 2003-08-21 | Disphar International B.V. | Pharmaceutical compositions |
| GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
| EP1336602A1 (en) | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| CN100430399C (zh) * | 2002-03-20 | 2008-11-05 | 昆士兰大学 | 包含一氧化氮供体和阿片样物质止痛剂的组合物和方法 |
| CA2379211A1 (fr) | 2002-03-28 | 2003-09-28 | Institut De Cardiologie De Montreal | Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase) |
| ATE372777T1 (de) | 2003-07-09 | 2007-09-15 | Us Gov Health & Human Serv | Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen |
| CA2536173A1 (en) | 2003-08-20 | 2005-03-03 | Nitromed, Inc. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| US20050113409A1 (en) | 2003-09-03 | 2005-05-26 | Pharmacia Corporation | Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith |
| US7362274B1 (en) | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
| US20060083824A1 (en) | 2004-10-20 | 2006-04-20 | Pbm Products Llc | Nutritional supplements for glucose intolerant individuals |
| AU2006249771A1 (en) | 2005-05-24 | 2006-11-30 | Wellgen, Inc. | Compositions and methods for the prevention and treatment of conditions associated with inflammation |
| GB0607402D0 (en) | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
| US8333997B2 (en) | 2006-06-21 | 2012-12-18 | Albert Einstein College Of Medicine Of Yeshiva University | Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof |
| JP2010519336A (ja) | 2007-02-26 | 2010-06-03 | ルンドベルク，ヨン | 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用 |
| US9180140B2 (en) | 2007-02-26 | 2015-11-10 | Heartbeet Ltd. | Performance enhancing composition and use thereof |
| WO2008153762A2 (en) | 2007-05-25 | 2008-12-18 | N30 Pharmaceuticals, Llc | S-nitrosothiol formulations and storage systems |
| EP2219657A4 (en) | 2007-11-15 | 2020-01-08 | Louisiana State University | USE OF NITRITE SALTS IN CHRONIC ISCHEMIA |
| JP2011507968A (ja) | 2007-12-27 | 2011-03-10 | エイヤーズ ファーマシューティカルズ、インク． | エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用 |
| WO2010036236A1 (en) | 2008-09-23 | 2010-04-01 | Baker Hughes Incorporated | Anchor assembly |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| WO2010147742A2 (en) | 2009-06-18 | 2010-12-23 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| JP5758904B2 (ja) * | 2009-10-14 | 2015-08-05 | セラバスク インコーポレーテッド | ニトライトの医薬製剤及びそれらの使用 |
| US20130209584A1 (en) * | 2009-10-14 | 2013-08-15 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| EP2533773B1 (en) * | 2010-10-21 | 2015-08-19 | Kipax Ab | Topical dermal delivery device for nitric oxide delivery |
| US20140127329A1 (en) | 2011-03-31 | 2014-05-08 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline |
| WO2012142413A2 (en) | 2011-04-14 | 2012-10-18 | Theravasc Inc. | Nitrite compositions and uses thereof |
| WO2014130691A2 (en) * | 2013-02-20 | 2014-08-28 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
-
2014
- 2014-02-20 WO PCT/US2014/017432 patent/WO2014130691A2/en active Application Filing
- 2014-02-20 KR KR1020157025763A patent/KR102472588B1/ko active IP Right Grant
- 2014-02-20 BR BR112015019802A patent/BR112015019802A2/pt not_active Application Discontinuation
- 2014-02-20 EP EP14754330.0A patent/EP2958573B1/en active Active
- 2014-02-20 ES ES14754330T patent/ES2741146T3/es active Active
- 2014-02-20 AU AU2014218916A patent/AU2014218916A1/en not_active Abandoned
- 2014-02-20 DK DK14754330.0T patent/DK2958573T3/da active
- 2014-02-20 CN CN201480022166.1A patent/CN105358160A/zh active Pending
- 2014-02-20 CA CA2899602A patent/CA2899602C/en active Active
- 2014-02-20 JP JP2015558225A patent/JP2016509030A/ja active Pending
-
2015
- 2015-02-19 US US14/626,571 patent/US9561249B2/en active Active
-
2016
- 2016-06-02 HK HK16106249.8A patent/HK1218079A1/zh unknown
-
2017
- 2017-01-05 US US15/399,208 patent/US20170143759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016509030A (ja) | 2016-03-24 |
| US20150196588A1 (en) | 2015-07-16 |
| US9561249B2 (en) | 2017-02-07 |
| ES2741146T3 (es) | 2020-02-10 |
| CA2899602A1 (en) | 2014-08-28 |
| WO2014130691A3 (en) | 2014-10-16 |
| AU2014218916A1 (en) | 2015-09-03 |
| EP2958573A2 (en) | 2015-12-30 |
| DK2958573T3 (da) | 2019-08-05 |
| CA2899602C (en) | 2024-01-30 |
| BR112015019802A2 (pt) | 2017-07-18 |
| CN105358160A (zh) | 2016-02-24 |
| KR20150120479A (ko) | 2015-10-27 |
| WO2014130691A2 (en) | 2014-08-28 |
| KR102472588B1 (ko) | 2022-12-01 |
| EP2958573A4 (en) | 2016-10-19 |
| EP2958573B1 (en) | 2019-05-08 |
| US20170143759A1 (en) | 2017-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222122A1 (zh) | 選擇性藥物遞送組合物及使用方法 | |
| ZA201602510B (en) | Strigolactone formulations and uses thereof | |
| HK1221416A1 (zh) | 氧雜雙環庚烷和氧雜雙環庚烯的配製品 | |
| IL265876A (en) | Preparations that include 15-ohepa and methods of using them | |
| EP2964235A4 (en) | ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE | |
| IL243608A0 (en) | Substances with antiviral activity, preparations containing them and their uses | |
| EP2981611A4 (en) | ANTIBIOTICUM PROTOCOLS AND PHARMACEUTICAL FORMULATIONS AND TREATMENT METHODS THEREWITH | |
| HUE044893T2 (hu) | Tûzálló készítmény és annak használata | |
| HK1220920A1 (zh) | 治療性組合物和其用途 | |
| HK1218855A1 (zh) | 干粉製劑及使用方法 | |
| HK1218079A1 (zh) | 亞硝酸鹽的藥物製劑及其用途 | |
| HK1215859A1 (zh) | 包含蜂膠提取物的治療性組合物和其用途 | |
| SG11201507389RA (en) | Integration of hydro-dechlorination and hydro-regeneration | |
| HK1219691A1 (zh) | 醫藥組成物及其用途 | |
| EP2994755A4 (en) | Therapeutic and imaging compositions and uses thereof | |
| PL3228313T3 (pl) | Postacie dawkowania i zastosowania terapeutyczne L-4-chlorokineureniny | |
| HK1204916A1 (zh) | 淫羊藿苷元的醫藥用途 | |
| GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same | |
| HK1217670A1 (zh) | 調配物、其製造方法和用途 | |
| EP3052475A4 (en) | Pharmaceutical use of 3-benzylsulfonylpropionitrile | |
| AU2013901834A0 (en) | Formulations and Therapeutic Uses Thereof | |
| GB201207064D0 (en) | Pharmaceutical compositions comprising 15-hetre and methods of using the same | |
| GB201300628D0 (en) | Compositions comprising 15-OHEPA and methods of using the same |